Search research articles
Contact Us
Filters
Showing results (171-180 of 182) with videos related to
Page
of 19
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 5, 2019
Impact of Autologous Transplantation in Patients with Multiple Myeloma with t(11;14): A Propensity-Score Matched Analysis
Neeraj Saini, Junsheng Ma, Denái R Milton, et al.
Neuro-Oncology
|
December 13, 2022
Changes in outcomes and factors associated with survival in melanoma patients with brain metastases
Merve Hasanov, Denái R Milton, Alicia Bea Davies, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 10, 2025
Long-Term Survival and Biomarker Analysis Evaluating Neoadjuvant Plus Adjuvant Relatlimab (anti-LAG3) and Nivolumab (anti-PD1) in Patients With Resectable Melanoma
Elizabeth M Burton, Denái R Milton, Michael T Tetzlaff, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
December 28, 2019
Outcome of Multiple Myeloma with Chromosome 1q Gain and 1p Deletion after Autologous Hematopoietic Stem Cell Transplantation: Propensity Score Matched Analysis
Ankur Varma, Dawen Sui, Denái R Milton, et al.
Bone Marrow Transplantation
|
February 15, 2024
Outcomes of toxoplasmosis after allogeneic hematopoietic stem cell transplantation and the role of antimicrobial prophylaxis
Alexandre E Malek, Taha Al-Juhaishi, Denái R Milton, et al.
The Journal of Investigative Dermatology
|
August 23, 2014
Beyond BRAF(V600): clinical mutation panel testing by next-generation sequencing in advanced melanoma
Alan E Siroy, Genevieve M Boland, Denái R Milton, et al.
Nature
|
October 26, 2022
Neoadjuvant relatlimab and nivolumab in resectable melanoma
Rodabe N Amaria, Michael Postow, Elizabeth M Burton, et al.
Nature Medicine
|
October 10, 2018
Neoadjuvant immune checkpoint blockade in high-risk resectable melanoma
Rodabe N Amaria, Sangeetha M Reddy, Hussein A Tawbi, et al.
Nature Microbiology
|
August 4, 2022
Antibiotic resistance genes in the gut microbiota of mothers and linked neonates with or without sepsis from low- and middle-income countries
M J Carvalho, K Sands, K Thomson, et al.
Nature
|
March 9, 2023
Author Correction: Neoadjuvant relatlimab and nivolumab in resectable melanoma
Rodabe N Amaria, Michael Postow, Elizabeth M Burton, et al.
Page
of 19
Search research articles
Search
Showing results (171-180 of 182) with videos related to
Sort By:
Page
of 19
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 5, 2019
Impact of Autologous Transplantation in Patients with Multiple Myeloma with t(11;14): A Propensity-Score Matched Analysis
Neeraj Saini, Junsheng Ma, Denái R Milton, et al.
Neuro-Oncology
|
December 13, 2022
Changes in outcomes and factors associated with survival in melanoma patients with brain metastases
Merve Hasanov, Denái R Milton, Alicia Bea Davies, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 10, 2025
Long-Term Survival and Biomarker Analysis Evaluating Neoadjuvant Plus Adjuvant Relatlimab (anti-LAG3) and Nivolumab (anti-PD1) in Patients With Resectable Melanoma
Elizabeth M Burton, Denái R Milton, Michael T Tetzlaff, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
December 28, 2019
Outcome of Multiple Myeloma with Chromosome 1q Gain and 1p Deletion after Autologous Hematopoietic Stem Cell Transplantation: Propensity Score Matched Analysis
Ankur Varma, Dawen Sui, Denái R Milton, et al.
Bone Marrow Transplantation
|
February 15, 2024
Outcomes of toxoplasmosis after allogeneic hematopoietic stem cell transplantation and the role of antimicrobial prophylaxis
Alexandre E Malek, Taha Al-Juhaishi, Denái R Milton, et al.
The Journal of Investigative Dermatology
|
August 23, 2014
Beyond BRAF(V600): clinical mutation panel testing by next-generation sequencing in advanced melanoma
Alan E Siroy, Genevieve M Boland, Denái R Milton, et al.
Nature
|
October 26, 2022
Neoadjuvant relatlimab and nivolumab in resectable melanoma
Rodabe N Amaria, Michael Postow, Elizabeth M Burton, et al.
Nature Medicine
|
October 10, 2018
Neoadjuvant immune checkpoint blockade in high-risk resectable melanoma
Rodabe N Amaria, Sangeetha M Reddy, Hussein A Tawbi, et al.
Nature Microbiology
|
August 4, 2022
Antibiotic resistance genes in the gut microbiota of mothers and linked neonates with or without sepsis from low- and middle-income countries
M J Carvalho, K Sands, K Thomson, et al.
Nature
|
March 9, 2023
Author Correction: Neoadjuvant relatlimab and nivolumab in resectable melanoma
Rodabe N Amaria, Michael Postow, Elizabeth M Burton, et al.
Page
of 19